| Alias | 科研级 Tefibazumab ( 替非组单抗 ), Anti-Fibrin-binding Surface Epitope Clumping Factor A Recombinant Antibody, Research Grade Tefibazumab |
| Catalog Number | YR1172 |
| Molecular Name | Tefibazumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus. |
| CAS Number | 521079-87-8 |
| Application | FCM, IP, ELISA, Neut, FuncS, IF |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | Fibrin-binding surface epitope clumping factor A[Staphylococcus aureus] |
销售微信
官方公众号
0
